NOVONIX LIMITED SEC Form 6-K Report: January 2025 Insights

Here are the key insights extracted from the provided section of the financial report:
- Report Type: The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC, typically used to disclose material information.
- Filing Date: The report is dated January 10, 2025, and pertains to the events for the month of January 2025.
- Company Information:
- Company Name: NOVONIX LIMITED
- Commission File Number: 001-41208
- Principal Executive Office Address:
- Level 38
- 71 Eagle Street
- Brisbane, QLD 4000, Australia
- Annual Report Filing: The company has indicated that it files annual reports under Form 20-F, which is typical for foreign registrants.
- Exhibit Index:
- Exhibit 99.1: Includes an Appendix 2A (Application for quotation of securities) dated January 10, 2025.
- Signatures:
- The report is signed by Dr. John Christopher Burns, who is the Chief Executive Officer of NOVONIX LIMITED.
- The signing date is also noted as January 10, 2025.
This report serves to provide updates and disclosures relevant to investors and regulatory authorities regarding the company's operations and compliance with SEC regulations.